Piper Sandler Cuts Trupanion (NASDAQ:TRUP) Price Target to $52.00

Trupanion (NASDAQ:TRUP) had its price target cut by Piper Sandler from $57.00 to $52.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s price objective points to a potential upside of 9.45% from the stock’s previous close.

A number of other analysts have also commented on the company. Northland Securities boosted their price objective on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Stifel Nicolaus boosted their price objective on Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $44.50.

Trupanion Stock Performance

Shares of Trupanion stock opened at $47.51 on Thursday. Trupanion has a one year low of $19.69 and a one year high of $57.90. The firm has a market capitalization of $2.01 billion, a price-to-earnings ratio of -148.47, a PEG ratio of 8.49 and a beta of 1.60. The business has a 50-day simple moving average of $48.54 and a 200 day simple moving average of $47.98. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. On average, research analysts anticipate that Trupanion will post -0.2 earnings per share for the current fiscal year.

Insider Transactions at Trupanion

In related news, SVP Emily Dreyer sold 3,100 shares of the company’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total value of $170,035.00. Following the transaction, the senior vice president now owns 24,708 shares in the company, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Fawwad Qureshi sold 622 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the transaction, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. The trade was a 5.93 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 14,681 shares of company stock worth $785,194 in the last 90 days. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Institutional investors have recently bought and sold shares of the company. SBI Securities Co. Ltd. purchased a new position in Trupanion in the fourth quarter valued at approximately $25,000. Jones Financial Companies Lllp lifted its stake in Trupanion by 71.7% in the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 238 shares during the last quarter. Quest Partners LLC purchased a new position in Trupanion in the third quarter valued at approximately $37,000. Quarry LP purchased a new position in Trupanion in the fourth quarter valued at approximately $39,000. Finally, Wilmington Savings Fund Society FSB purchased a new position in Trupanion in the third quarter valued at approximately $54,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.